Resero Analytics

Resero Analytics offers an AI/ML-enabled software platform designed to unify and automate the nonclinical research process for pharmaceutical and biotech companies. The TurboPlatform consolidates functions from study setup and data capture to analysis and regulatory submission-ready outputs (like SEND datasets and CTD summaries) into one architecture. This addresses critical industry pain points around data silos, manual reconciliation, and compliance, aiming to accelerate timelines and reduce operational burdens. The company targets the growing digital health and diagnostics tools market within life sciences R&D.

TurboPlatform: A unified, cloud-based software architecture with integrated applications (TurboLIMS, TurboToxicology, TurboPKTK, TurboBioA) for managing the nonclinical study lifecycle. It features a protocol-driven data model, native regulatory output generation (SEND, CTD), AI/automation capabilities, and a single validation framework compliant with GLP and 21 CFR Part 11.

Resero competes with established nonclinical LIMS vendors, standalone toxicology/PK analysis software, and legacy system providers. Its key differentiation is the unified, end-to-end platform architecture versus the typical fragmented ecosystem of point solutions and custom integrations. It also competes with large clinical data platform companies that may expand into the preclinical space.